메뉴 건너뛰기




Volumn 48, Issue 18, 2012, Pages 3456-3464

Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma - A phase II trial of the childhood liver tumour strategy group (SIOPEL)

(16)  Zsíros, József a   Brugières, Laurence b   Brock, Penelope c   Roebuck, Derek c   Maibach, Rudolf d   Child, Margaret e   Morland, Bruce f   Casanova, Michela g   Pariente, Daniele h   Paris, Claudia i   Camargo, Beatriz De j   Ronghe, Milind k   Zimmermann, Arthur l   Plaschkes, Jack m   Czauderna, Piotr n   Perilongo, Giorgio o  


Author keywords

Camptothecin; Child; Clinical trial phase II; Hepatoblastoma; Irinotecan; Liver cancer

Indexed keywords

IRINOTECAN;

EID: 84869491003     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.06.023     Document Type: Article
Times cited : (46)

References (36)
  • 1
    • 0034669523 scopus 로고    scopus 로고
    • Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach - Results of the first prospective study of the International Society of Pediatric Oncology
    • J. Pritchard, J. Brown, and E. Shafford Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: A successful approach - results of the first prospective study of the International Society of Pediatric Oncology J Clin Oncol 18 2000 3819 3828
    • (2000) J Clin Oncol , vol.18 , pp. 3819-3828
    • Pritchard, J.1    Brown, J.2    Shafford, E.3
  • 3
    • 0037102268 scopus 로고    scopus 로고
    • Treatment of unresectable and metastatic hepatoblastoma: A pediatric oncology group phase II study
    • H.M. Katzenstein, W.B. London, and E.C. Douglass Treatment of unresectable and metastatic hepatoblastoma: A pediatric oncology group phase II study J Clin Oncol 20 2002 3438 3444
    • (2002) J Clin Oncol , vol.20 , pp. 3438-3444
    • Katzenstein, H.M.1    London, W.B.2    Douglass, E.C.3
  • 4
    • 84869126053 scopus 로고    scopus 로고
    • High dose chemotherapy does not improve the overall survival of children with hepatoblastoma
    • B. Haberle, I. Schmid, and U. Bode High dose chemotherapy does not improve the overall survival of children with hepatoblastoma Pediatr Blood Cancer 51 2008 53
    • (2008) Pediatr Blood Cancer , vol.51 , pp. 53
    • Haberle, B.1    Schmid, I.2    Bode, U.3
  • 5
    • 70350333890 scopus 로고    scopus 로고
    • Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma
    • G. Perilongo, R. Maibach, and E. Shafford Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma N Engl J Med 361 2009 1662 1670
    • (2009) N Engl J Med , vol.361 , pp. 1662-1670
    • Perilongo, G.1    Maibach, R.2    Shafford, E.3
  • 6
    • 77956405067 scopus 로고    scopus 로고
    • Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: Final results of the SIOPEL-3HR study
    • J. Zsíros, R. Maibach, and E. Shafford Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study J Clin Oncol 28 2010 2584 2590
    • (2010) J Clin Oncol , vol.28 , pp. 2584-2590
    • Zsíros, J.1    Maibach, R.2    Shafford, E.3
  • 7
    • 84869492137 scopus 로고    scopus 로고
    • Childhood liver tumours
    • Stevens MCG, Caron HN, Biondi A, editors Oxford: Oxford University Press
    • Perilongo G, Zsiros J. Childhood liver tumours. In: Stevens MCG, Caron HN, Biondi A, editors. Cancer in children. Oxford: Oxford University Press; 2011.
    • (2011) Cancer in Children
    • Perilongo, G.1    Zsiros, J.2
  • 8
    • 0032820520 scopus 로고    scopus 로고
    • Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: A report of the German cooperative pediatric liver tumor study HB 89 and HB 94
    • J. Fuchs, U. Bode, and D. Von Schweinitz Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: A report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94 Klin Padiatr 211 1999 305 309 (Pubitemid 29364773)
    • (1999) Klinische Padiatrie , vol.211 , Issue.4 , pp. 305-309
    • Fuchs, J.1    Bode, U.2    Schweinitz, D.V.3    Weinel, P.4    Erttmann, R.5    Harms, D.6    Mildenberger, H.7
  • 11
    • 84869498661 scopus 로고    scopus 로고
    • Relapses in hepatoblastoma patients: Clinical characteristics and outcome: Experience of the International Childhood Liver Tumour strategy Group - SIOPEL
    • M. Semerano, L. Brugieres, and J. Zsiros Relapses in hepatoblastoma patients: clinical characteristics and outcome: experience of the International Childhood Liver Tumour strategy Group - SIOPEL Pediatr Blood Cancer 53 2009 746
    • (2009) Pediatr Blood Cancer , vol.53 , pp. 746
    • Semerano, M.1    Brugieres, L.2    Zsiros, J.3
  • 12
    • 84855894118 scopus 로고    scopus 로고
    • Salvage strategies
    • A. Zimmermann, G. Perilongo, M. Malogolowkin, D. Von Schweinitz, Springer-Verlag Berlin Heidelberg
    • J. Zsíros, and L. Brugieres Salvage strategies A. Zimmermann, G. Perilongo, M. Malogolowkin, D. Von Schweinitz, Pediatric liver tumors 2011 Springer-Verlag Berlin Heidelberg 34 45
    • (2011) Pediatric Liver Tumors , pp. 34-45
    • Zsíros, J.1    Brugieres, L.2
  • 22
    • 54449087562 scopus 로고    scopus 로고
    • A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)
    • G. Vassal, F. Giammarile, and M. Brooks A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d'Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG) Eur J Cancer 44 2008 2453 2460
    • (2008) Eur J Cancer , vol.44 , pp. 2453-2460
    • Vassal, G.1    Giammarile, F.2    Brooks, M.3
  • 25
    • 0029964873 scopus 로고    scopus 로고
    • Characterisation and clinical management of CPT-11 (Irinotecan)-induced adverse events: The European perspective
    • H. Bleiberg, and E. Cvitkovic Characterisation and clinical management of CPT-11 (Irinotecan)-induced adverse events: the European perspective Eur J Cancer 32 1996 S18 S23
    • (1996) Eur J Cancer , vol.32
    • Bleiberg, H.1    Cvitkovic, E.2
  • 26
    • 0032130703 scopus 로고    scopus 로고
    • Gastrointestinal toxicity of Irinotecan
    • J.R. Hecht Gastrointestinal toxicity of Irinotecan Oncology 12 1998 S72 S78
    • (1998) Oncology , vol.12
    • Hecht, J.R.1
  • 28
    • 0032169909 scopus 로고    scopus 로고
    • Camptothecins: A review of their development and schedules of administration
    • DOI 10.1016/S0959-8049(98)00229-9, PII S0959804998002299
    • J. O'Leary, and F.M. Muggia Camptothecins: A review of their development and schedules of administration Eur J Cancer 34 1998 1500 1508 (Pubitemid 28446329)
    • (1998) European Journal of Cancer , vol.34 , Issue.10 , pp. 1500-1508
    • O'Leary, J.1    Muggia, F.M.2
  • 29
    • 0034594628 scopus 로고    scopus 로고
    • New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
    • P. Therasse, S.G. Arbuck, and E.A. Eisenhauer New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
    • (2000) J Natl Cancer Inst , vol.92 , pp. 205-216
    • Therasse, P.1    Arbuck, S.G.2    Eisenhauer, E.A.3
  • 30
    • 0032984458 scopus 로고    scopus 로고
    • Multinomial phase II cancer trials incorporating response and early progression
    • DOI 10.1081/BIP-100101181
    • B. Zee, D. Melnychuk, J. Dancey, and E. Eisenhauer Multinomial phase II cancer trials incorporating response and early progression J Biopharma Stat 9 1999 351 363 (Pubitemid 29262953)
    • (1999) Journal of Biopharmaceutical Statistics , vol.9 , Issue.2 , pp. 351-363
    • Zee, B.1    Melnychuk, D.2    Dancey, J.3    Eisenhauer, E.4
  • 33
    • 0037734135 scopus 로고    scopus 로고
    • Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11)
    • DOI 10.1002/mpo.10300
    • R.D. Palmer, and D.M. Williams Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11) Med Pediatr Oncol 41 2003 78 80 (Pubitemid 41103263)
    • (2003) Medical and Pediatric Oncology , vol.41 , Issue.1 , pp. 78-80
    • Palmer, R.D.1    Williams, D.M.2
  • 34
    • 33745727139 scopus 로고    scopus 로고
    • Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan
    • O. Ijichi, S. Ishikawa, and Y. Shinkoda Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan Pediatr Transplant 10 2006 635 638
    • (2006) Pediatr Transplant , vol.10 , pp. 635-638
    • Ijichi, O.1    Ishikawa, S.2    Shinkoda, Y.3
  • 36
    • 33846951814 scopus 로고    scopus 로고
    • Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: The children's oncology group
    • DOI 10.1200/JCO.2006.07.1720
    • A.S. Pappo, E. Lyden, and P. Breitfeld Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group J Clin Oncol 25 2007 362 369 (Pubitemid 350002984)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.4 , pp. 362-369
    • Pappo, A.S.1    Lyden, E.2    Breitfeld, P.3    Donaldson, S.S.4    Wiener, E.5    Parham, D.6    Crews, K.R.7    Houghton, P.8    Meyer, W.H.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.